Your browser doesn't support javascript.
loading
Defining migraine days, based on longitudinal E-diary data.
van der Arend, Britt W H; Verhagen, Iris E; van Leeuwen, Matthijs; van der Arend, Marnick Q T P; van Casteren, Daphne S; Terwindt, Gisela M.
Affiliation
  • van der Arend BWH; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
  • Verhagen IE; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
  • van Leeuwen M; Leiden Institute of Advanced Computer Science, Leiden University, Leiden, The Netherlands.
  • van der Arend MQTP; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
  • van Casteren DS; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
  • Terwindt GM; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Cephalalgia ; 43(5): 3331024231166625, 2023 05.
Article in En | MEDLINE | ID: mdl-37021643
ABSTRACT

BACKGROUND:

There is a need for standardization of the definition of a migraine day for clinical and research purposes.

METHODS:

We prospectively compared different definitions of a migraine day with E-diary data of n = 1494 patients with migraine. We used a baseline definition based on migraine characteristics with a duration of ≥4 hours OR triptan intake (independently from its effect) OR (visual) aura lasting 5-60 minutes.

RESULTS:

Of all migraine days defined by triptan intake only, 66.2% had a duration <4 hours. Adjusting the headache duration criterion to ≥30 minutes led to a decrease in days defined by triptan intake only and resulted in a 5.4% increase in total migraine days (equals 0.45 migraine day increase in monthly migraine days). These additional migraine days had a median duration of 2.5 hours.

CONCLUSION:

We propose to define a migraine day as follows 1) (a) headache duration ≥30 minutes; (b) matching ≥2 of four characteristics unilateral, pulsating, moderate to severe pain, aggravation by or causing avoidance of routine physical activity; and (c) during headache ≥1 of the following nausea and/or vomiting, photophobia and phonophobia or 2) (visual) aura duration 5-60 minutes or 3) a day with headache for which acute migraine-specific medication is used irrespective of its effect.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Epilepsy / Migraine Disorders Limits: Humans Language: En Journal: Cephalalgia Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Epilepsy / Migraine Disorders Limits: Humans Language: En Journal: Cephalalgia Year: 2023 Document type: Article Affiliation country:
...